Cargando…

Activated p38 MAPK in Peripheral Blood Monocytes of Steroid Resistant Asthmatics

Steroid resistance is a significant problem in management of chronic inflammatory diseases, including asthma. Accessible biomarkers are needed to identify steroid resistant patients to optimize their treatment. This study examined corticosteroid resistance in severe asthma. 24 asthmatics with forced...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ling-bo, Leung, Donald Y. M., Goleva, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627650/
https://www.ncbi.nlm.nih.gov/pubmed/26517722
http://dx.doi.org/10.1371/journal.pone.0141909
_version_ 1782398310091325440
author Li, Ling-bo
Leung, Donald Y. M.
Goleva, Elena
author_facet Li, Ling-bo
Leung, Donald Y. M.
Goleva, Elena
author_sort Li, Ling-bo
collection PubMed
description Steroid resistance is a significant problem in management of chronic inflammatory diseases, including asthma. Accessible biomarkers are needed to identify steroid resistant patients to optimize their treatment. This study examined corticosteroid resistance in severe asthma. 24 asthmatics with forced expiratory volume in one second of less then 80% predicted were classified as steroid resistant or steroid sensitive based on changes in their lung function following a week of treatment with oral prednisone. Heparinised blood was collected from patients prior to oral prednisone administration. Phosphorylated mitogen activated kinases (MAPK) (extracellular regulated kinase (ERK), p38 and jun kinase (JNK)) were analyzed in whole blood samples using flow cytometry. Activation of phospho-p38 MAPK and phospho-mitogen- and stress-activated protein kinase 1 (MSK1) in asthmatics’ peripheral blood mononuclear cells (PBMC) were confirmed by Western blot. Dexamethasone suppression of the LPS-induced IL-8 mRNA production by steroid resistant asthmatics PBMC in the presence of p38 and ERK inhibitors was evaluated by real time PCR. Flow cytometry analysis identified significantly stronger p38 phosphorylation in CD14(+) monocytes from steroid resistant than steroid sensitive asthmatics (p = 0.014), whereas no difference was found in phosphorylation of ERK or JNK in CD14(+) cells from these two groups of asthmatics. No difference in phosphorylated p38, ERK, JNK was detected in CD4(+), CD8(+) T cells, B cells and NK cells from steroid resistant vs. steroid sensitive asthmatics. P38 MAPK pathway activation was confirmed by Western blot, as significantly higher phospho-p38 and phospho-MSK1 levels were detected in the PBMC lysates from steroid resistant asthmatics. P38 inhibitor significantly enhanced DEX suppression of LPS-induced IL-8 mRNA by PBMC of steroid resistant asthmatics. This is the first report demonstrating selective p38 MAPK pathway activation in blood monocytes of steroid resistant asthmatics, suggesting that p38 and MSK1 phosphorylation can serve as blood biomarkers of steroid resistance.
format Online
Article
Text
id pubmed-4627650
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46276502015-11-06 Activated p38 MAPK in Peripheral Blood Monocytes of Steroid Resistant Asthmatics Li, Ling-bo Leung, Donald Y. M. Goleva, Elena PLoS One Research Article Steroid resistance is a significant problem in management of chronic inflammatory diseases, including asthma. Accessible biomarkers are needed to identify steroid resistant patients to optimize their treatment. This study examined corticosteroid resistance in severe asthma. 24 asthmatics with forced expiratory volume in one second of less then 80% predicted were classified as steroid resistant or steroid sensitive based on changes in their lung function following a week of treatment with oral prednisone. Heparinised blood was collected from patients prior to oral prednisone administration. Phosphorylated mitogen activated kinases (MAPK) (extracellular regulated kinase (ERK), p38 and jun kinase (JNK)) were analyzed in whole blood samples using flow cytometry. Activation of phospho-p38 MAPK and phospho-mitogen- and stress-activated protein kinase 1 (MSK1) in asthmatics’ peripheral blood mononuclear cells (PBMC) were confirmed by Western blot. Dexamethasone suppression of the LPS-induced IL-8 mRNA production by steroid resistant asthmatics PBMC in the presence of p38 and ERK inhibitors was evaluated by real time PCR. Flow cytometry analysis identified significantly stronger p38 phosphorylation in CD14(+) monocytes from steroid resistant than steroid sensitive asthmatics (p = 0.014), whereas no difference was found in phosphorylation of ERK or JNK in CD14(+) cells from these two groups of asthmatics. No difference in phosphorylated p38, ERK, JNK was detected in CD4(+), CD8(+) T cells, B cells and NK cells from steroid resistant vs. steroid sensitive asthmatics. P38 MAPK pathway activation was confirmed by Western blot, as significantly higher phospho-p38 and phospho-MSK1 levels were detected in the PBMC lysates from steroid resistant asthmatics. P38 inhibitor significantly enhanced DEX suppression of LPS-induced IL-8 mRNA by PBMC of steroid resistant asthmatics. This is the first report demonstrating selective p38 MAPK pathway activation in blood monocytes of steroid resistant asthmatics, suggesting that p38 and MSK1 phosphorylation can serve as blood biomarkers of steroid resistance. Public Library of Science 2015-10-30 /pmc/articles/PMC4627650/ /pubmed/26517722 http://dx.doi.org/10.1371/journal.pone.0141909 Text en © 2015 Li et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Li, Ling-bo
Leung, Donald Y. M.
Goleva, Elena
Activated p38 MAPK in Peripheral Blood Monocytes of Steroid Resistant Asthmatics
title Activated p38 MAPK in Peripheral Blood Monocytes of Steroid Resistant Asthmatics
title_full Activated p38 MAPK in Peripheral Blood Monocytes of Steroid Resistant Asthmatics
title_fullStr Activated p38 MAPK in Peripheral Blood Monocytes of Steroid Resistant Asthmatics
title_full_unstemmed Activated p38 MAPK in Peripheral Blood Monocytes of Steroid Resistant Asthmatics
title_short Activated p38 MAPK in Peripheral Blood Monocytes of Steroid Resistant Asthmatics
title_sort activated p38 mapk in peripheral blood monocytes of steroid resistant asthmatics
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627650/
https://www.ncbi.nlm.nih.gov/pubmed/26517722
http://dx.doi.org/10.1371/journal.pone.0141909
work_keys_str_mv AT lilingbo activatedp38mapkinperipheralbloodmonocytesofsteroidresistantasthmatics
AT leungdonaldym activatedp38mapkinperipheralbloodmonocytesofsteroidresistantasthmatics
AT golevaelena activatedp38mapkinperipheralbloodmonocytesofsteroidresistantasthmatics